[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Agricultural Biologicals Market, 2023-2035: Distribution by Type of Product (Biopesticides / Biocontrols, Biofertilizers and Biostimulants), Source of Product (Microbes, Plant Extracts and Other Sources), Mode of Application (Foliar Sprays, Seed Treatments, Soil Treatments and Other Application Methods) Type of Crop Treated (Cereals and Pulses, Fruits and Nuts, Green Fodder, Vegetables and Tubers, Oilseeds, Industrial Crops, Textile Crops and Others) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts

September 2023 | 308 pages | ID: AF09B6185903EN
Roots Analysis

US$ 4,799.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global agricultural biologics market is expected to reach USD 13.76 billion by 2023 anticipated to grow at a CAGR of 9.98% during the forecast period 2023-2035.

Agricultural biologicals, also referred to as agricultural biologics, cover a wide range of items like biopesticides, biofertilizers, and biostimulants. These products are sourced from natural elements such as microorganisms, plant extracts, beneficial insects, or other organic matter. Their main aim is to boost soil fertility, stimulate biological processes, and support plant growth. Notably, they are eco-friendly, leaving no harmful residues in ecosystems. They also help reduce potential risks to farmers' and consumers' health typically linked to chemical pesticides and fertilizers. Years of intense agricultural practices and excessive use of chemical pesticides and fertilizers have negatively affected soil quality by reducing beneficial microorganisms. This has led to compromised crop health and diminished soil fertility. Agricultural biologics, including biopesticides, biofertilizers, and biostimulants, are increasingly used to reduce dependence on traditional chemical inputs.

Furthermore, these biological products are fundamental to sustainable agriculture and organic farming systems. They play a crucial role in addressing the growing food demand due to the expanding global population. They also align with consumer preferences for organic food, promoting sustainable farming practices. Consequently, the agricultural biologicals market is expected to witness significant growth in the forecast period.

Report Coverage
  • The report examines the agricultural biologics market across various parameters such as type of product, source of product, mode of application, type of crop treated and key geographical regions
  • Analysis is conducted on factors influencing market growth, including drivers, restraints, opportunities, and challenges.
  • Evaluation of potential advantages and barriers within the market landscape is provided, alongside insights into the competitive environment for leading market players.
  • Revenue forecasts for market segments are presented concerning five significant regions.
  • A detailed explanation is given regarding the systematic research approach employed to study the agricultural biologics market, encompassing methodologies, assumptions, and quality control measures aimed at ensuring precision and reliability of findings.
  • Historical trends and economic influences such as currency fluctuations, foreign exchange impacts, recession, and inflation are examined in their relation to the agricultural biologics market.
  • A concise summary offers major findings and an overarching perspective on the current status and anticipated evolution of the agricultural biologicals market across short, medium, and long-term timelines.
  • Various agricultural biologics are described based on their functions, emphasizing their advantages in the agricultural sector. This section explores opportunities, future prospects, and the increasing necessity for such crop protection products.
  • Companies offering agricultural biologics are thoroughly evaluated based on parameters like establishment year, company size, headquarters location, product types offered, formulations, applications, and their significance in the market.
  • Comprehensive analysis of company competitiveness considers supplier strength, encompassing experience and company size, and product portfolio strength, including product types, crop variety, sources, applications, and formulations.
  • Elaborate profiles are provided for top companies in agricultural biologics, featuring company overviews, financial performance (if available), product portfolios, recent developments, and future prospects.
  • A comprehensive review is conducted on partnerships between agricultural biologics companies, encompassing distribution agreements, acquisitions, product development collaborations, research agreements, and more since 2020.
  • In-depth examination of patents filed/granted related to agricultural biologics since 2019 is presented, considering publication year, geographical distribution, leading players, and patent valuation. This includes benchmarking of significant patents based on citations.
  • Thorough assessment is performed on competitive forces impacting the agricultural biologicals market, covering threats from new entrants, bargaining power of developers and end-users, substitute products, and rivalry among competitors.
  • Detailed analysis identifies drivers, restraints, opportunities, and challenges influencing the growth of the agricultural biologicals market.
Key Market Companies
  • AMVAC
  • Andermatt
  • BASF SE
  • Bayer AG
  • BioSafe Systems
  • Brandt
  • Chr. Hansen
  • Certis Biologicals
  • Corteva Agriscience
  • FBSciences
  • Grow Indigo
  • Koppert Biological Systems
  • Lallemand
  • Nutri-Tech Solutions
  • Novozymes
  • PI Industries
  • ProFarm
  • SQM
  • Stoller
  • Syngenta AG
  • UPL
  • Vegalab
  • Valent Biosciences
  • Verdisian Life Sciences
1. PREFACE

1.1. Agricultural Biologicals Market Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
  2.7.1. Demographics
  2.7.2. Economic Factors
  2.7.3. Government Regulations
  2.7.4. Supply Chain
  2.7.5. COVID Impact / Related Factors
  2.7.6. Market Access
  2.7.7. Healthcare Policies
  2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview
3.2. Market Dynamics
  3.2.1. Time Period
    3.2.1.1. Historical Trends
    3.2.1.2. Current and Forecasted Estimates
  3.2.2. Currency Coverage
    3.2.2.1. Overview of Major Currencies Affecting the Market
    3.2.2.2. Impact of Currency Fluctuations on the Industry
  3.2.3. Foreign Exchange Impact
    3.2.3.1. Evaluation of Foreign Exchange Rates and their Impact on Market
    3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
  3.2.4. Recession
    3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
    3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
  3.2.5. Inflation
    3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview
5.2. Sustainable Agriculture
5.3. Introduction to Agricultural Biologicals
  5.3.1. Types of Agricultural Biologicals
    5.3.1.1. Biostimulants
    5.3.1.2. Biopesticides / Biocontrols
    5.3.1.3. Biofertilizers
  5.3.2. Advantages of Agricultural Biologicals
5.4. Future Perspectives

6. MARKET LANDSCAPE

6.1. Chapter Overview
6.2. Agricultural Biologicals Manufacturers: Overall Market Landscape
  6.2.1. Analysis by Year of Establishment
  6.2.2. Analysis by Company Size
  6.2.3. Analysis by Year of Establishment and Company Size
  6.2.4. Analysis by Location of Headquarters
  6.2.5. Analysis by Company Size and Location of Headquarters
  6.2.6. Analysis by Type of Product Offered
  6.2.7. Analysis by Company Size and Type of Product Offered
  6.2.8. Analysis by Source of Product Offered
  6.2.9. Analysis by Type of Product Formulation
  6.2.10. Analysis by Type of Crop Treated
  6.2.11. Analysis by Mode of Application
  6.2.12. Analysis by Number of Products Offered
  6.2.13. Most Active Players: Analysis by Number of Products Offered

7. COMPANY COMPETITIVENESS ANALYSIS

7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in North America
  7.4.1 Very Small and Small Companies in North America
  7.4.2. Mid-sized Companies in North America
  7.4.3. Large and Very Large Companies in North America
7.5. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Europe
  7.5.1. Very Small and Small Companies in Europe
  7.5.2. Mid-sized Companies in Europe
  7.5.3. Large and Very Large Companies in Europe
7.6. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Asia-Pacific and Rest of the World
  7.6.1. Very Small and Small Companies in Asia-Pacific and Rest of the World
  7.6.2. Mid-sized Companies in Asia-Pacific and Rest of the World
  7.6.3. Large and Very Large Companies in Asia-Pacific and Rest of the World
7.7. Company Competitiveness Analysis: Other Agricultural Biologicals Manufacturers

8. COMPANY PROFILES

8.1. Chapter Overview
8.2. Leading Players in Agricultural Biologicals Market
  8.2.1. Andermatt
    8.2.1.1. Company Overview
    8.2.1.2. Agricultural Biologicals Portfolio
    8.2.1.3. Recent Developments and Future Outlook
  8.2.2. Certis Biologicals
    8.2.2.1. Company Overview
    8.2.2.2. Agricultural Biologicals Portfolio
    8.2.2.3. Recent Developments and Future Outlook
  8.2.3. Corteva Agriscience
    8.2.3.1. Company Overview
    8.2.3.2. Financial Information
    8.2.3.3. Agricultural Biologicals Portfolio
    8.2.3.4. Recent Developments and Future Outlook
  8.2.4. Nutri-Tech Solutions
    8.2.4.1. Company Overview
    8.2.4.2. Agricultural Biologicals Portfolio
    8.2.4.3. Recent Developments and Future Outlook
  8.2.5. Novozymes
    8.2.5.1. Company Overview
    8.2.5.2. Financial Information
    8.2.5.3. Agricultural Biologicals Portfolio
    8.2.5.4. Recent Developments and Future Outlook
  8.2.6. ProFarm
    8.2.6.1. Company Overview
    8.2.6.2. Agricultural Biologicals Portfolio
    8.2.6.3. Recent Developments and Future Outlook
  8.2.7. SQM
    8.2.7.1. Company Overview
    8.2.7.2. Agricultural Biologicals Portfolio
    8.2.7.3. Recent Developments and Future Outlook
  8.2.8. UPL
    8.2.8.1. Company Overview
    8.2.8.2. Financial Information
    8.2.8.3. Agricultural Biologicals Portfolio
    8.2.8.4. Recent Developments and Future Outlook
  8.2.9. Vegalab
    8.2.9.1. Company Overview
    8.2.9.2. Agricultural Biologicals Portfolio
    8.2.9.3. Recent Developments and Future Outlook
8.3. Other Leading Players in Agricultural Biologicals Market
  8.3.1. AMVAC
    8.3.1.1. Company Overview
    8.3.1.2. Agricultural Biologicals Portfolio
  8.3.2. BASF
    8.3.2.1. Company Overview
    8.3.2.2. Agricultural Biologicals Portfolio
  8.3.3. Bayer
    8.3.3.1. Company Overview
    8.3.3.2. Agricultural Biologicals Portfolio
  8.3.4. BioSafe Systems
    8.3.4.1. Company Overview
    8.3.4.2. Agricultural Biologicals Portfolio
  8.3.5. Brandt
    8.3.5.1. Company Overview
    8.3.5.2. Agricultural Biologicals Portfolio
  8.3.6. Chr. Hansen
    8.3.6.1. Company Overview
    8.3.6.2. Agricultural Biologicals Portfolio
  8.3.7. FBSciences
    8.3.7.1. Company Overview
    8.3.7.2. Agricultural Biologicals Portfolio
  8.3.8. Grow Indigo
    8.3.8.1. Company Overview
    8.3.8.2. Agricultural Biologicals Portfolio
  8.3.9. Koppert
    8.3.9.1. Company Overview
    8.3.9.2. Agricultural Biologicals Portfolio
  8.3.10. Lallemand
    8.3.10.1. Company Overview
    8.3.10.2. Agricultural Biologicals Portfolio
  8.3.11. PI Industries
    8.3.11.1. Company Overview
    8.3.11.2. Agricultural Biologicals Portfolio
  8.3.12. Stoller
    8.3.12.1. Company Overview
    8.3.12.2. Agricultural Biologicals Portfolio
  8.3.13. Syngenta
    8.3.13.1. Company Overview
    8.3.13.2. Agricultural Biologicals Portfolio
  8.3.14. Valent Biosciences
    8.3.14.1. Company Overview
    8.3.14.2. Agricultural Biologicals Portfolio
  8.3.15. Verdesian Life Sciences
    8.3.15.1. Company Overview
    8.3.15.2. Agricultural Biologicals Portfolio

9. PARTNERSHIPS AND COLLABORATIONS

9.1. Chapter Overview
9.2. Partnership Models
9.3. Agricultura Biologicals: Recent Partnerships and Collaborations
  9.3.1. Analysis by Year of Partnership
  9.3.2. Analysis by Type of Partnership
  9.3.3. Analysis by Year and Type of Partnership
  9.3.4. Analysis by Type of Partnership and Company Size
  9.3.5. Analysis by Focus Area of Partnership
  9.3.6. Analysis by Type of Partner
  9.3.7. Most Active Players: Analysis by Number of Partnerships
  9.3.8 Analysis by Geography
    9.3.8.1. Local and International Agreements
    9.3.8.2. Intracontinental and Intercontinental Agreements

10. PATENT ANALYSIS

10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Agricultural Biologicals: Patent Analysis
  10.3.1. Analysis by Patent Publication Year
  10.3.2. Analysis by Patent Application Year
  10.3.3. Analysis of Granted Patents and Patent Applications by Publication Year
  10.3.4. Analysis by Patent Jurisdiction
  10.3.5. Analysis by CPC Symbols
  10.3.6. Analysis by Type of Applicant
  10.3.7. Leading Industry Players: Analysis by Number of Patents
  10.3.8. Leading Non-Industry Players: Analysis by Number of Patents
  10.3.9. Leading Individual Assignees: Analysis by Number of Patents
10.4. Agricultural Biologicals: Patent Benchmarking Analysis
  10.4.1. Analysis by Patent Characteristics
10.5. Agricultural Biologicals: Patent Valuation
10.6. Leading Patents by Number of Citations

11. PORTER’S FIVE FORCES ANALYSIS

11.1. Chapter Overview
11.2. Methodology and Assumptions
11.3. Key Parameters
  11.3.1. Threats of New Entrants
  11.3.2. Bargaining Power of End-Users
  11.3.3. Bargaining Power of Product Developers
  11.3.4. Threats of Substitute Products
  11.3.5. Rivalry Among Existing Competitors
11.4. Concluding Remarks

12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion

13. GLOBAL AGRICULTURAL BIOLOGICALS MARKET

13.1. Chapter Overview
13.2. Assumptions and Methodology
13.3. Global Agricultural Biologicals Market, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  13.3.1. Scenario Analysis
13.4. Key Market Segmentations
13.5. Dynamic Dashboard

14. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF PRODUCT

14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Agricultural Biologicals Market: Distribution by Type of Product, 2019, 2023 and 2035 (USD Billion)
  14.3.1. Biopesticides / Biocontrols Market: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  14.3.2. Biofertilizers Market: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  14.3.3. Biostimulants Market: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
14.4. Data Triangulation
  14.4.1. Insights based on Primary Research
  14.4.2. Insights based on Secondary Research

15. AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE OF PRODUCT

15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Agricultural Biologicals Market: Distribution by Source of Product, 2019, 2023 and 2035 (USD Billion)
  15.3.1. Agricultural Biologicals Market for Microbes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  15.3.2. Agricultural Biologicals Market for Plant Extracts: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  15.3.3. Agricultural Biologicals Market for Other Sources: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
15.4. Data Triangulation
  15.4.1. Insights based on Primary Research
  15.4.2. Insights based on Secondary Research

16. AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION

16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Agricultural Biologicals Market: Distribution by Mode of Application, 2019, 2023 and 2035 (USD Billion)
  16.3.1. Agricultural Biologicals Market for Foliar Sprays: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  16.3.2. Agricultural Biologicals Market for Seed Treatments: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  16.3.3. Agricultural Biologicals Market for Soil Treatments: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  16.3.4. Agricultural Biologicals Market for Other Application Methods: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
16.4. Data Triangulation
  16.4.1. Insights based on Primary Research
  16.4.2. Insights based on Secondary Research

17. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF CROP TREATED

17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Agricultural Biologicals Market: Distribution by Type of Crop Treated, 2019, 2023 and 2035 (USD Billion)
  17.3.1. Agricultural Biologicals Market for Cereals and Pulses: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  17.3.2. Agricultural Biologicals Market for Fruits and Nuts: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  17.3.3. Agricultural Biologicals Market for Oilseeds: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  17.3.4. Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  17.3.5. Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.4. Data Triangulation
  17.4.1. Insights based on Secondary Research

18. AGRICULTURAL BIOLOGICALS MARKET, BY GEOGRAPHY

18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Agricultural Biologicals Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035 (USD Billion)
  18.3.1. Agricultural Biologicals Market for North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  18.3.2. Agricultural Biologicals Market for Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  18.3.3. Agricultural Biologicals Market for Aisa-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  18.3.4. Agricultural Biologicals Market for Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
  18.3.5. Agricultural Biologicals Market for Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.4. Data Triangulation
  18.4.1. Insights based on Primary Research
  18.4.2. Insights based on Secondary Research

19. CONCLUSION

20. EXECUTIVE INSIGHTS

20.1. Chapter Overview
20.2. Vegalab
  20.2.1. Company Snapshot
  20.2.2. Interview Transcript: David Selakovic, President
20.3. Acadian Plant Health
  20.3.1. Company Snapshot
  20.3.2. Interview Transcript: Shannon Wentz, Global Director
20.4. Jiahe Biology
  20.4.1. Company Snapshot
  20.4.2. Interview Transcript: Zhange, Sales Representative

21. APPENDIX 1: TABULATED DATA

22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS


More Publications